Stanford University
Showing 29,041-29,060 of 34,414 Results
-
Lisa Marie Swan
Advanced Lecturer, Program in Writing and Rhetoric
BioLisa Swan teaches writing courses. She has served as the PWR 1 Coordinator supporting the curricular, pedagogical, and professional development of the first year writing requirement and developed a summer bridge writing course and a support workshop for students who are first generation college students, from low-income backgrounds, or attended underresourced schools. She holds a Ph.D. in Curriculum and Instruction with a specialization in English Education from the University of Maryland, College Park. Previously, she taught at the University of Maryland and Northern Virginia Community College. At Stanford, her writing class themes have focused on educational equity, comics and graphic novels, the future of cities, and student voice. Her research interests include writing studies, composition and reading pedagogies, curriculum design, and qualitative research methods.
-
Nick Swan
Director of Student Academic Experience, H&S Dean's Office
Current Role at StanfordStudent Services Officer, Physics Department.
-
James Swartz
Emeritus Faculty, Academic Council, Chemical Engineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Andrew Sweatt
Assistant Professor of Medicine (PACCM)
Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.
